// App-Quantinova.ai

: Multiple Breath Washout (MBW) training, certification and quality control during the iBEST-1 trial in bronchiectasis (BE).

Researchers

Presenter

  • Katherine O'Neill

Principal Investigators

  • Michael M. Tunney

  • Gerhild Angyalosi

  • Charles Haworth

  • Michael R. Loebinger

  • Judy M. Bradley

  • J. Stuart Elborn

Medical Centers

  • Wellcome-Wolfson Institute of Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • School of Pharmacy, Queen's University , Belfast, United Kingdom

  • Novartis AG, Basel, Switzerland

  • Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, United Kingdom

  • Host Defence Unit, Royal Bromptom Hospital, London, United Kingdom

  • Wellcome-Wolfson Institute for Experimental Medicine, Clinical Research Facility, Belfast, United Kingdom

  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast; Host Defence Unit, Royal Brompton Hospital, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A